BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 3085698)

  • 1. Plasma levels of nitroglycerin generated by three nitroglycerin patch preparations, Nitradisc, Transiderm-Nitro and Nitro-Dur and one ointment formulation, Nitrobid.
    McAllister A; Mosberg H; Settlage JA; Steiner JA
    Br J Clin Pharmacol; 1986 Apr; 21(4):365-9. PubMed ID: 3085698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma nitroglycerin concentrations and hemodynamic effects of sublingual, ointment, and controlled-release forms of nitroglycerin.
    Curry SH; Kwon HR; Perrin JH; Culp JR; Pepine CJ; Yu WC; Stevens JL
    Clin Pharmacol Ther; 1984 Dec; 36(6):765-72. PubMed ID: 6437723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitroglycerin concentration in plasma: comparison between transdermal therapeutic system and ointment.
    Chu LC; Gale RM; Schmitt LG; Shaw JE
    Angiology; 1984 Sep; 35(9):545-52. PubMed ID: 6435484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacokinetics and relative bioavailability of a nitroglycerin ointment formulation (author's transl)].
    Maier-Lenz H; Ringwelski L; Windorfer A
    Arzneimittelforschung; 1980; 30(2):320-4. PubMed ID: 6769443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the safety and efficacy of topical nitroglycerin ointment to facilitate venous cannulation.
    Griffith P; James B; Cropp A
    Nurs Res; 1994; 43(4):203-6. PubMed ID: 8047423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of a new transdermal nitroglycerin adhesive patch formulation.
    Riedel DJ; Wick KA; Hawkinson RW; Kolars CA; Crowley JK; Armstrong KE; Chang SF; Harrison LI; de Dennis SR
    Clin Ther; 1989; 11(2):225-31. PubMed ID: 2500248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative evaluation of two transdermal nitroglycerin delivery systems: Nitro-Dur versus Transderm-Nitro. The Collaborative Investigation Group.
    Clin Ther; 1991; 13(5):545-9. PubMed ID: 1799911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmaceutical considerations of transdermal nitroglycerin delivery: the various approaches.
    Chien YW
    Am Heart J; 1984 Jul; 108(1):207-16. PubMed ID: 6428207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacodynamics of a nitroglycerin ointment in patients with stenocardia of effort].
    Romakov AIu; Sagirov AM; Sumarokov AB; Mazur NA
    Kardiologiia; 1985 Apr; 25(4):41-4. PubMed ID: 3927053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of nitroglycerin ointment placement on the severity of headache and flushing in patients with cardiac disease.
    Riegel B; Heywood G; Jackson W; Kennedy A
    Heart Lung; 1988 Jul; 17(4):426-31. PubMed ID: 3134314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of dose and ointment application technique on nitroglycerin plasma concentrations.
    Iafrate RP; Yost RL; Curry SH; Gotz VP; Caranasos GJ
    Pharmacotherapy; 1983; 3(2 Pt 1):118-24. PubMed ID: 6406987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perianal versus endoanal application of glyceryl trinitrate 0.4% ointment in the treatment of chronic anal fissure: results of a randomized controlled trial. Is this the solution to the headaches?
    Pérez-Legaz J; Arroyo A; Moya P; Ruiz-Tovar J; Frangi A; Candela F; Oliver MI; Calpena R
    Dis Colon Rectum; 2012 Aug; 55(8):893-9. PubMed ID: 22810476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of adhesive properties of two transdermal nitroglycerin controlled-release systems.
    Chinoy DA; Breaux PC; Ibrahim F
    Clin Ther; 1985; 8(1):30-4. PubMed ID: 3938681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of nitroglycerin ointment placement on headache and flushing in healthy subjects.
    Shively M; Riegel B
    Int J Nurs Stud; 1991; 28(2):153-61. PubMed ID: 1910019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative acceptance of three transdermal nitroglycerin placebo patches.
    Rayment CM; Kaul AF; Garfield JM
    Am J Hosp Pharm; 1985 Jun; 42(6):1362-5. PubMed ID: 3925770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modified-release ointment with nitroglycerin β-cyclodextrin inclusion complex for treatment of anal fissures.
    Centkowska K; Sznitowska M
    J Pharm Pharmacol; 2013 Oct; 65(10):1463-72. PubMed ID: 24028613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of nitroglycerin ointments in the rabbit.
    Ritschel WA; Ritschel-Beurlin G; Grummich K
    Arzneimittelforschung; 1980; 30(3):432-5. PubMed ID: 6770874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adhesion-to-skin performance of a new transdermal nitroglycerin adhesive patch.
    Wick KA; Wick SM; Hawkinson RW; Holtzman JL
    Clin Ther; 1989; 11(3):417-24. PubMed ID: 2501033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application site for nitroglycerin ointment.
    Hansen MS
    Am J Cardiol; 1978 Dec; 42(6):1061. PubMed ID: 103418
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.